Skip to main content

Table 1 Subject characteristics of asthma (A) and healthy (H) subjects

From: In vivo imaging of the airway wall in asthma: fibered confocal fluorescence microscopy in relation to histology and lung function

 

A

H

  

Total

HA

HNA

Subjects (n)

8

8

5

3

Male/Female (n)

2/6

4/4

2/3

2/1

Age (years) a

24 (2)

28 (10)

30 (12)

23 (2)

FEV 1 /FVC (%pred.)a,*

96 (9)

108 (7)

105 (7)

113 (4)

Post-bronchodilator FEV 1

(%pred.) a

108 (11)

115 (6)

115 (6)

114 (6)

Dose response slope (% decline FEV 1 /μmol methacholine)b,**

6.49

(3.47-31.30)

0.20

(0.04-0.30)

0.23

(0.10-0.49)

0.07

(0.03-0.23)

  1. Total = all healthy control subjects; HA = healthy, atopic; HNA = healthy, non-atopic
  2. a Mean (SD)
  3. b Median (P25-P75)
  4. * A vs. Total p = 0.012; A vs. HNA p = 0.016
  5. ** A vs. Total p = 0.001; A vs. HA p = 0.003; A vs. HNA p = 0.014